Abu-Arja, MH; Osorio, DS; Lassaletta, A; Graham, RT; Coven, SL; Stanek, JR; Bouffet, E; Finlay, JL; Abdelbaki, MS.
Prognostic factors for patients with relapsed central nervous system nongerminomatous germ cell tumors.
Pediatric Blood and Cancer.
2022;
69.
Al Atrash, E; Abdullah, MF; Pressey, J; Mohan, S.
GIST presenting as refractory iron-deficiency anaemia in paediatric patient.
BMJ Case Reports.
2022;
15.
Azhar, M; Kincaid, Z; Kesarwani, M; Menke, J; Sweiterman, J; Ansari, S; Reaves, A; Ahmed, A; Shahzad, R; Khan, A; et al.
Rational polypharmacological targeting of FLT3, JAK2, ABL, and ERK1 suppresses the adaptive resistance to FLT3 inhibitors in AML.
Blood Advances.
2022.
Barreyro, L; Sampson, AM; Ishikawa, C; Hueneman, KM; Choi, K; Pujato, MA; Chutipongtanate, S; Wyder, M; Haffey, WD; O'Brien, E; et al.
Blocking UBE2N abrogates oncogenic immune signaling in acute myeloid leukemia.
Science Translational Medicine.
2022;
14.
Brungardt, JG; Burns, KC; Dasgupta, R.
Fertility preservation in children and young adults with cancer.
Current Opinion in Pediatrics.
2022;
34:48-52.
Budde, A; Baust, K; Weinhold, L; Bernstein, M; Bielack, S; Dhooge, C; Hjorth, L; Janeway, KA; Jenney, M; Krailo, MD; et al.
Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma.
European Journal of Cancer.
2022;
170:209-235.
Cacciotti, C; Chordas, C; Valentino, K; Allen, R; Lenzen, A; Burns, K; Nagarajan, R; Manley, P; Pillay-Smiley, N.
Cardiac dysfunction in medulloblastoma survivors treated with photon irradiation.
2022;
9:338-343.
Chihanga, T; Vicente-Muñoz, S; Ruiz-Torres, S; Pal, B; Sertorio, M; Andreassen, PR; Khoury, R; Mehta, P; Davies, SM; Lane, AN; et al.
Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia.
Cancers.
2022;
14.
D’Alessandro, PR.
Research-Based Theater in the Pediatric Oncology Setting: Balancing Ethical Tensions.
Qualitative Inquiry.
2022.
D'Alessandro, P.
Commentary on McNeil et al. and Wolfe et al.
2022;
6:1-1.
D'Alessandro, PR; Lo, AC; Spencer, MH; Farinha, P; Armstrong, L; Dolman, PJ; Cheng, S.
Primary cutaneous follicle center lymphoma of the medial canthus of the eye in an 11-year old.
Pediatric Blood and Cancer.
2022;
69.
de Blank, PM K; Gross, AM; Akshintala, S; Blakeley, JO; Bollag, G; Cannon, A; Dombi, E; Fangusaro, J; Gelb, BD; Hargrave, D; et al.
MEK Inhibitors for Neurofibromatosis Type 1 Manifestations: Clinical Evidence and Consensus.
Neuro-Oncology.
2022.
Dewire, M; Lazow, M; Campagne, O; Leach, J; Fuller, C; Senthil Kumar, S; Stanek, J; De Blank, P; Hummel, TR; Pillay-Smiley, N; et al.
Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report.
Neuro-Oncology Advances.
2022;
4.
Fabrizio, VA; Phillips, CL; Lane, A; Baggott, C; Prabhu, S; Egeler, E; Mavroukakis, S; Pacenta, H; Rossoff, J; Stefanski, HE; et al.
Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report.
Blood Advances.
2022;
6:600-610.
Geller, JI; Vandenheuval, K; Smith, E; Kotagal, M; Pater, L.
Pediatric Renal Tumors.
Pediatric Nephrology.
2022.
Gracia-Maldonado, G; Clark, J; Burwinkel, M; Greenslade, B; Wunderlich, M; Salomonis, N; Leone, D; Gatti, E; Pierre, P; Kumar, AR; et al.
LAMP-5 is an essential inflammatory-signaling regulator and novel immunotherapy target for mixed lineage leukemia-rearranged acute leukemia.
Haematologica.
2022;
107:803-815.
Greene, AN; Nguyen, ET; Paranjpe, A; Lane, A; Privette Vinnedge, LM; Solomon, MB.
In silico gene expression and pathway analysis of DEK in the human brain across the lifespan.
European Journal of Neuroscience.
2022;
56:4720-4743.
Hegde, S; Gasilina, A; Wunderlich, M; Lin, Y; Buchholzer, M; Krumbach, OH F; Akbarzadeh, M; Ahmadian, MR; Seibel, W; Zheng, Y; et al.
Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemia.
Leukemia.
2022;
36:637-647.
Jones, LQ M; Starczynowski, DT.
IKAROS and MENIN in synergy in AML.
2022;
3:528-529.
Kotch, C; Avery, R; Getz, KD; Bouffet, E; De Blank, P; Listernick, R; Gutmann, DH; Bornhorst, M; Campen, C; Liu, GT; et al.
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1.
Neuro-Oncology.
2022;
24:1377-1386.
Lazow, MA; Nievelstein, MT; Lane, A; Bandopadhayhay, P; DeWire-Schottmiller, M; Fouladi, M; Glod, JW; Greiner, RJ; Hoffman, LM; Hummel, TR; et al.
Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry.
Neuro-Oncology.
2022;
24:1598-1608.
Lin, S; Larrue, C; Scheidegger, NK; Seong, BK A; Dharia, NV; Kuljanin, M; Wechsler, CS; Kugener, G; Robichaud, AL; Conway, AS; et al.
An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML.
Cancer Discovery.
2022;
12:432-449.
Majzner, RG; Ramakrishna, S; Yeom, KW; Patel, S; Chinnasamy, H; Schultz, LM; Richards, RM; Jiang, L; Barsan, V; Mancusi, R; et al.
GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.
Nature.
2022;
603:934-941.
McBee, MP; Woodhouse, C; Trout, AT; Geller, JI; Smith, EA; Zhang, B; Towbin, AJ.
Skeletal muscle mass as a marker to predict outcomes in children and young adults with cancer.
Abdominal Radiology.
2022;
47:452-459.
McGrady, ME; Perez, MN; Bernstein, J; Strenk, M; Kiger, MA; Norris, RE.
Adherence and Barriers to Inpatient Physical Therapy Among Adolescents and Young Adults with Hematologic Malignancies.
Journal of Adolescent and Young Adult Oncology.
2022.
Merjaneh, N; Young, J; Mangoli, A; Olsen, M; Setty, B; Lane, A; Nagarajan, R; Pressey, JG; Turpin, B.
Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care.
Pediatric Blood and Cancer.
2022;
69.
Moskop, A; Pommert, L; Baggott, C; Prabhu, S; Pacenta, HL; Phillips, CL; Rossoff, J; Stefanski, HE; Talano, JA; Margossian, SP; et al.
Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia.
Blood Advances.
2022;
6:4251-4255.
Muhammad, B; Parks, LG; Komurov, K; Privette Vinnedge, LM.
Defective transcription elongation in human cancers imposes targetable proteotoxic vulnerability.
Translational Oncology.
2022;
16.
Muraleedharan, R; Dasgupta, B.
AMPK in the brain: its roles in glucose and neural metabolism.
FEBS Journal.
2022;
289:2247-2262.
Muto, T; Guillamot, M; Yeung, J; Fang, J; Bennett, J; Nadorp, B; Lasry, A; Redondo, LZ; Choi, K; Gong, Y; et al.
TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity.
Cell Stem Cell.
2022;
29:298-314.e9.
Niederkorn, M; Ishikawa, C; M. Hueneman, K; Bartram, J; Stepanchick, E; R. Bennett, J; E. Culver-Cochran, A; Bolanos, LC; Uible, E; Choi, K; et al.
The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia.
Leukemia.
2022;
36:438-451.
O'Brien, MM; Ji, L; Shah, NN; Rheingold, SR; Bhojwani, D; Yuan, CM; Xu, X; Yi, JS; Harris, AC; Brown, PA; et al.
(2022)
Phase II Trial of Inotuzumab Ozogamicin in Children and Adolescents With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: Children's Oncology Group Protocol AALL1621.
40:956-967.
Odia, Y; Koschmann, C; Tarapore, R; Allen, J; Hall, M; Daghistani, D; Khatib, Z; Aguilera, D; MacDonald, T; de Blank, P; et al.
SYST-07 WINDOW-OF-OPPORTUNITY STUDY OF ONC201 IN PEDIATRIC PATIENTS WITH DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) AND THALAMIC GLIOMA.
Neuro-Oncology Advances.
2022;
4:i22-i22.
Perazzo, D; Moore, R; Kasparian, NA; Rodts, M; Horowitz-Kraus, T; Crosby, L; Turpin, B; Beck, AF; Hutton, J.
Chronic pediatric diseases and risk for reading difficulties: a narrative review with recommendations.
Pediatric Research.
2022.
Pommert, L; Cooper, TM; Gerbing, RB; Brodersen, L; Loken, M; Gamis, A; Aplenc, R; Alonzo, TA; Kolb, EA.
Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival.
Cancers.
2022;
14.
Pommert, L; Schafer, ES; Malvar, J; Gossai, N; Florendo, E; Pulakanti, K; Heimbruch, K; Stelloh, C; Chi, YY; Sposto, R; et al.
Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
American Journal of Hematology.
2022;
97:613-622.
Power-Hays, A; Dandoy, CE; Lorts, A; Perentesis, JP; Unaka, N; Ware, RE; McGann, PT.
US News & World Report and quality metrics: Inclusion of sickle cell disease is a matter of equity.
Pediatric Blood and Cancer.
2022;
69.
Rubinstein, JD; Jodele, S; Heyenbruch, D; Wilhelm, J; Thomas, S; Lutzko, C; Zhu, X; Leemhuis, T; Cancelas, JA; Keller, M; et al.
Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients.
Transplantation and cellular therapy.
2022;
28:116.e1-116.e7.
Rubinstein, JD; Lutzko, C; Leemhuis, T; Zhu, X; Pham, G; Ray, L; Thomas, S; Dourson, C; Wilhelm, J; Lane, A; et al.
Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant.
Blood Advances.
2022;
6:2897-2907.
Sabulski, A; Grier, DD; Myers, KC; Davies, SM; Rubinstein, JD.
Acute myeloid leukemia in SRP54-mutated congenital neutropenia.
2022;
3:521-525.
Scheuermann, A; Harker-Murray, P; Pommert, L.
Posterior Reversible Encephalopathy Syndrome in the Setting of Asparaginase-associated Pancreatitis in 2 Pediatric Patients With Acute Leukemia.
Journal of Pediatric Hematology/Oncology.
2022;
44:e709-e712.
Schultz, LM; Baggott, C; Prabhu, S; Pacenta, HL; Phillips, CL; Rossoff, J; Stefanski, HE; Talano, JA; Moskop, A; Margossian, SP; et al.
Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report.
Journal of Clinical Oncology.
2022;
40:945-955.
Silva de Araujo, BE; Velleuer, E; Dietrich, R; Pomjanski, N; de Santana Almeida Araujo, IK; Schlensog, M; Wells, SI; Dorsman, JC; Schramm, M.
Detection of cytogenetic changes and chromosomal aneuploidy with fluorescent in situ hybridization in cytological specimens of oral cancers in Fanconi anemia-Proof of concept.
Clinical and Experimental Dental Research.
2022;
8:108-116.
Thapaliya, S; Sung, AJ; Sharp, SE; Turpin, BK; Zhang, B; Nehus, EJ; Trout, AT.
Agreement between serum estimates of glomerular filtration rate (GFR) and a reference standard of radioisotopic GFR in children with cancer.
Pediatric Radiology.
2022;
52:903-909.
Vicente-Muñoz, S; Hunt, BG; Lange, TE; Wells, SI; Waltz, SE.
NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival.
PLoS ONE.
2022;
17.
Williams, MT; Sugimoto, C; Regan, SL; Pitzer, EM; Fritz, AL; Sertorio, M; Mascia, AE; Vatner, RE; Perentesis, JP; Vorhees, CV.
Cognitive and behavioral effects of whole brain conventional or high dose rate (FLASH) proton irradiation in a neonatal Sprague Dawley rat model.
PLoS ONE.
2022;
17.